Navigation Links
Merck & Co., Inc. Named Keynote Sponsor For Diversity Alliance For Science's Inaugural Conference
Date:3/28/2008

Global Pharmaceutical Company Supports Organization's National Networking

And Expo Event

MORRISTOWN, N.J., March 28 /PRNewswire/ -- Diversity Alliance for Science, Inc. (DA4S) (http://www.diversityallianceforscience.com) has announced that Merck & Co., Inc. will serve as the keynote sponsor for its inaugural networking conference and expo scheduled for May 19-20 at the Westin Governors in Morristown, N.J. The two-day event will focus on developing and integrating more minority, women, veteran and disabled-owned businesses into the life sciences space. The national event is expected to draw top-level pharmaceutical executives, high-ranking government officials and CEOs of diverse scientific and clinical enterprises.

Merck & Co, Inc. is one of the largest pharmaceutical companies in the world. Established in 1891 and headquartered in Whitehouse Station, N.J., the company discovers, develops, manufactures and markets a broad range of products aimed at improving human and animal health. Merck has 59,800-plus employees worldwide and products sold in more than 140 countries. The company boasts a Manufacturing Division, which employs more than 12,000 people at locations in 25 countries, as well as The Merck Research Laboratories, which employs approximately 9,500 people at sites in the U.S., Canada, Europe and Asia. Through The Merck Foundation, founded in 1957, the company has distributed more than $480 million to educational and nonprofit organizations worldwide.

"Merck's success has been built from the diversity of its employees and from a diverse customer base," said Sally Macaluso, senior director of global procurement for Merck & Co., Inc. "One of Merck's key corporate objectives is to grow supplier diversity spend to support the diverse communities in which we do business. As such, Merck is a proud sponsor of Diversity Alliance For Science's 'Diversity Creates Scientific Innovation Conference and Expo.'"

About Diversity Alliance for Science, Inc. (DA4S):

Diversity Alliance for Science, Inc. (DA4S) is a nonprofit organization aimed to provide pharmaceutical/bio-tech companies, academic medical centers and governmental agencies the ability to identify, develop, mentor and partner with woman, minority, veteran and disabled-owned enterprises (both large and small) in the life sciences industry. For more information, please visit http://www.diversityallianceforscience.com.

Patty Briguglio

MMI Associates, Inc.

(919) 233-6600

patty@mmimarketing.com

PR Firms Raleigh, NC


'/>"/>
SOURCE Diversity Alliance for Science, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. KineMed to Collaborate With Merck KgaA to Validate New Applications for Drug Development Candidates
2. ZymoGenetics and Merck Serono Receive FDA Special Protocol Assessment for Atacicept Pivotal Study in Lupus Nephritis
3. Merck Will Obtain Blockbuster Antidiabetic Drug Sales in Type 2 Diabetes Market by 2011
4. Pfizer, Genentech, Amgen, Bayer, Wyeth, Abbott, Merck and Additional Leading Pharmaceutical Companies Participating During ExL Pharmas Fall Line Up!
5. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Second Generation Niacin Receptor Agonist Under Its Collaboration With Merck & Co., Inc.
6. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
7. Todd R. Nelson Named Chief Executive Officer of eBioscience, Inc.
8. Miaxis Biometrics Named as Red Herring 100 Asia Award Winner for 2007
9. Dr. Keith Wilson Named President and Chief Scientific Officer of Takeda San Diego
10. Hyaluron Contract Manufacturing Named a 2007 Economic Impact Award Finalist
11. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... Lawrence, MA (PRWEB) , ... June 23, 2016 ... ... the Peel Plate® YM (Yeast and Mold) microbial test has received AOAC Research ... test platform of microbial tests introduced last year,” stated Bob Salter, Vice President ...
Breaking Biology Technology:
(Date:5/20/2016)... -- VoiceIt is excited to announce its new marketing ... working together, VoiceIt and VoicePass will offer an ... slightly different approaches to voice biometrics, collaboration between ... Both companies ... "This marketing and technology partnership allows VoiceIt ...
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a ... the MegaMatcher Automated Biometric Identification System (ABIS) ... large-scale multi-biometric projects. MegaMatcher ABIS can process multiple ... using any combination of fingerprint, face or iris ... MegaMatcher SDK and MegaMatcher Accelerator , ...
(Date:4/26/2016)... -- Research and Markets has announced the ...  report to their offering.  , ,     (Logo: ... forecast the global multimodal biometrics market to grow ... 2016-2020.  Multimodal biometrics is being implemented ... healthcare, BFSI, transportation, automotive, and government for controlling ...
Breaking Biology News(10 mins):